A Mixed-Methods Protocol to Identify Best Practices for Implementing Pharmacogenetic Testing in Clinical Settings
Using a patient’s genetic information to inform medication prescriptions can be clinically effective; however, the practice has not been widely implemented. Health systems need guidance on how to engage with providers to improve pharmacogenetic test utilization. Approaches from the field of implemen...
Main Authors: | Nina R. Sperber, Deborah Cragun, Megan C. Roberts, Lisa M. Bendz, Parker Ince, Sarah Gonzales, Susanne B. Haga, R. Ryanne Wu, Natasha J. Petry, Laura Ramsey, Ryley Uber |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/8/1313 |
Similar Items
-
P554: Cost not a barrier for adopters of pharmacogenetic testing: Results from a study of causal models in different healthcare systems
by: Nina Sperber, et al.
Published: (2024-01-01) -
Pharmacogenetic Review: Germline Genetic Variants Possessing Increased Cancer Risk With Clinically Actionable Therapeutic Relationships
by: Austin A. Saugstad, et al.
Published: (2022-05-01) -
Editorial: Brief research reports in pharmacogenetics and pharmacogenomics: 2022
by: Francesco Sessa, et al.
Published: (2023-03-01) -
Pharmacogenetic Testing in an Academic Psychiatric Clinic: A Retrospective Chart Review
by: Lisa Brown, et al.
Published: (2021-09-01) -
Application of pharmacogenetics in oncology
by: Nelly N. Miteva-Marcheva, et al.
Published: (2020-08-01)